43 reports

##.

  • DNA
  • RNA
  • World
  • Forecast
  • Market Size

RNA Therapies in Oncology: Analytical Tool RNA therapies, such as miRNA, RNAi & amp; siRNA, is an emerging class of biopharmaceutical that has immense potential in cancer medicine.

  • Oncology
  • Pharmaceutical
  • RNA
  • Therapy
  • World

Global DNA and RNA Isolation Kits Figure ##.

  • DNA
  • Genomics
  • RNA
  • APAC
  • World

Targeted DNA/ RNA Sequencing Market Analysis By Technology, By Workflow, By Application, By Type, By End-use And Segment Forecasts, 2014 - 2025 Chapter ## Research Methodology ##. ## Information Procurement ##. ##. ## Purchased Database ##. ##. ## GVR’s Internal Database ##. ## Data Analysis ##.

  • Genomics
  • RNA
  • United States
  • Demand
  • Forecast
  • NORTH AMERICA: RNA-FISH MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • GLOBAL RNA-FISH MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)

The in situ hybridization market is projected to reach USD 739.9 million by 2021 from USD 557.1 million in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). Increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, increasing government initiatives globally are some...

  • RNA
  • United States
  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Other prominent vendors
  • Global nucleic acid isolation and purification market 2016-2021 ($ mn)

It offers product such as bioZOLTM-G RNA Isolation Reagent and All-in-One (RNA/ DNA/ Protein) Purification Kit.

  • RNA
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare Limited
  • Thermo Fisher Scientific, Inc.
  • DORMANT PROJECTS, H1 2017
  • DORMANT PROJECTS, H1 2018

Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H1 2018 Summary According to the recently published report ’Probable ATP Dependent RNA Helicase DDX58 - Pipeline Review, H1...

  • Hepatitis
  • RNA
  • United States
  • World
  • Rigontec GmbH
  • RNA Aptamer
  • 6.3 RNA-BASED APTAMERS

The global aptamers market is expected to reach $244.93 million by 2020 from $107.56 million in 2015, growing at a CAGR of 17.89% between 2015 and 2020. The aptamer type segments included in this report are DNA-based aptamers, RNA-based aptamers, and XNA-based aptamers. Based on applications, the report is segmented into diagnostics, therapeutics...

  • RNA
  • United States
  • Base Pair Biotechnologies, Inc.
  • SomaLogic, Inc.
  • Vivonics, Inc.

Indicated by CTC cfDNA-RNA 2015 participants (Study ##) Table ##. ##.

  • Genomics
  • In Vitro Diagnostics
  • Molecular Diagnostic
  • RNA
  • LOW REPRESENTATION OF MIRNA AMONG RNA SPECIES
  • THREE: MIRNA PROFILING AND FUNCTIONAL ANALYSIS TECHNOLOGIES 73

MicroRNA Tools and Services Market examines the overall market for miRNA analysis tools and services. The miRNA marketplace is dynamic, driven by constant innovation and translation of scientific knowledge to clinical applications. The report includes the following market information: Estimated Market Breakdown by Tools...

  • RNA
  • Illumina, Inc.
  • Mirna Therapeutics, Inc.
  • QIAGEN N.V.
  • Sigma-Aldrich

RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other.

  • Genomics
  • In Vitro Diagnostics
  • Molecular Diagnostic
  • RNA
  • Market Shares

RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other.

  • Genomics
  • In Vitro Diagnostics
  • Molecular Diagnostic
  • RNA
  • Demand

RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other.

  • Genomics
  • In Vitro Diagnostics
  • Molecular Diagnostic
  • RNA
  • Demand
  • RNA Disruption Assay - Breast Cancer - Product Description
  • RNA Disruption Assay - Breast Cancer - Product Status

Summary Rna Diagnostics Inc (Rna Diagnostics) is a medical device company that discovers and develops medical diagnostics molecular diagnostic technologies.The company offers diagnostic tools used in treatment of women undergoing chemotherapy for breast cancer. It also provides solutions to manage cancer and other...

  • Breast Cancer
  • Diagnostics
  • RNA
  • Canada
  • Company
  • R&D Progress Research and Development Brief
  • R&D Progress Research and Development Brief

Probable ATP Dependent RNA Helicase DDX## (DEAD Box Protein ## or RIG I Like Receptor ## or Retinoic Acid Inducible Gene ## Protein or DDX## or EC ##. ##. ##. ##) - Pipeline Review, H## 2017 Reference Code: GMDHC##TDB Publication Date: November 2017 Introduction GLOBAL MARKETS DI

  • DNA
  • RNA
  • World
  • Product Initiative
  • Rigontec GmbH
  • Absolutely Total RNA Purification Kits Absolutely RNA 96 Microprep Kit
  • 8.3 TOTAL RNA ISOLATION AND PURIFICATION

The global nucleic acid isolation and purification market projected to grow at a CAGR of 9.6%. The global nucleic acid isolation and purification market is expected to reach USD 4.38 billion by 2023 from USD 2.77 billion in 2018, at a CAGR of 9.6%. Market growth is mainly driven by factors such as increasing public-private funding for...

  • RNA
  • North America
  • United States
  • Forecast
  • QIAGEN N.V.
  • 2.2.3 RNA
  • 2.3.4 CIRCULATING RNA IN PREGNANCY

ES.1 Introduction to the Non-invasive Prenatal Diagnostics Market The aim of this report was to review recent advances in use of circulating cell-free miRNA, DNA and mRNA as novel biomarkers which can be used as a non-invasive method for prenatal diagnostics. The report will also provide a market analysis of the market value,...

  • RNA
  • Ariosa Diagnostics, Inc.
  • Illumina, Inc.
  • Natera, Inc.
  • Sequenom, Inc.
  • ESYSTEM - QUALITATIVE HCV RNA ASSAY - PRODUCT STATUS
  • HCV RNA REAL-TIME PCR KIT - PRODUCT STATUS

Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2018 Summary GlobalData’s Medical Devices sector report, “Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2018" provides an overview of Hepatitis Test Kits currently in pipeline stage. The report provides comprehensive information...

  • Clinical Trial
  • Hepatitis
  • In Vitro Diagnostic Reagent
  • RNA
  • Abbott
  • EOSCAPE-HCV RNA - PRODUCT STATUS
  • FTD HEPATITIS C RNA ASSAY - PRODUCT DESCRIPTION

Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Medical Devices Pipeline Assessment, 2017" provides an overview of Hepatitis Viruses Rapid Tests & POC (Point Of Care)...

  • Hepatitis
  • RNA
  • United States
  • Demand
  • GlobalData's company
  • 2.2.3 RNA
  • 2.2.2 CIRCULATING EXTRACELLULAR DNA

ES.1 Introduction to the Circulating Nucleic Acid Market Report The aim of this report was to review recent advances in use of circulating cell-free miRNA, DNA and mRNA as novel biomarkers which can be used for the detection and diagnosis of cancer, and the impact on making the ongoing research closer to clinical application. The...

  • RNA
  • World
  • Affymetrix, Inc.
  • QIAGEN N.V.
  • Roche Group
  • MAY 15, 2018: EXOSOME DIAGNOSTICS PRESENTS BREAKTHROUGH DATA HIGHLIGHTING TUMOR DERIVED RNA IN BIOFLUIDS AT THE INTERNATIONAL SOCIETY FOR EXTRACELLULAR VESICLES IN SPAIN
  • Exosome Diagnostics Enters into Agreement with Takeda Pharma

Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions.The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA profiling, mutation...

  • Diagnostics
  • Medical Device
  • RNA
  • United States
  • Exosome Diagnostics, Inc.
  • ESYSTEM - QUALITATIVE HCV RNA ASSAY - PRODUCT DESCRIPTION
  • ESYSTEM - QUALITATIVE HCV RNA ASSAY - PRODUCT STATUS

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Hepatitis Viruses Diagnostic Tests currently in pipeline stage. The report...

  • Clinical Trial
  • Hepatitis
  • Molecular Diagnostic
  • RNA
  • GlobalData's company
  • RESQ-RNA
  • RESQ-RNA PRODUCT OVERVIEW

Summary SomaGenics Inc (SomaGenics) is a biotech company that develops and commercializes therapeutic agents.The company offers small RNA technologies, including RNAi-based therapeutics using sshRNA molecules, and diagnostics or biomarker detection of small or fragmented RNA, including microRNAs. It provides small...

  • Molecular Diagnostic
  • RNA
  • United States
  • Company Operations
  • SomaGenics, Inc.
  • EOSCAPE-HCV RNA
  • EOSCAPE-HCV RNA Product Overview

Summary Wave 80 Biosciences Inc (Wave 80) is a medical device company that develops molecular diagnostic instruments and consumables.The company develops molecular diagnostics instruments for chlamydia, respiratory illness, cancers, autoimmune diseases, hepatitis B, hepatitis C, HIV/AIDS and other human health conditions. It...

  • Hepatitis
  • Infectious Disease
  • Pathology
  • RNA
  • Tuberculosis
  • FEB 11, 2016: QIAGEN LAUNCHES TARGETED RNA PANELS FOR NEXT-GENERATION SEQUENCING
  • APR 14, 2016: QIAGEN LAUNCHES STREAMLINED BIOINFORMATICS FOR RNA SEQUENCING OF LIQUID BIOPSIES

Summary Qiagen NV (Qiagen) is a provider of molecular testing solutions.The company offers consumable products, instruments and automation systems. The company’s sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue; assay technologies to identify the genetic information...

  • Healthcare
  • Medical Device
  • Molecular Diagnostic
  • RNA
  • QIAGEN N.V.
  • MAR 23, 2017: NANOSTRING LAUNCHES NEW PLEXSET TECHNOLOGY AS AN ALTERNATIVE TO QPCR FOR MULTIPLEXED HIGH-THROUGHPUT GENE EXPRESSION STUDIES
  • Deal Type

The nCounter Low RNA Input Kit enables nCounter Gene Expression analysis to be performed with sample inputs ranging from ##-## ng, depending on sample quality.

  • Medical Device
  • RNA
  • United States
  • Company
  • NanoString Technologies, Inc.
  • RANA THERAPEUTICS ENTERS INTO LICENSING AGREEMENT WITH SANTARIS PHARMA TO DEVELOP RNA-TARGETED MEDICINES
  • JUN 27, 2017: RANA THERAPEUTICS RELAUNCHES AS TRANSLATE BIO TO ADVANCE RNA THERAPEUTICS

Summary Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression.The company provides platform oligonucleotides (oligos) are molecules designed to target specific areas...

  • Pharmaceutical
  • RNA
  • Therapy
  • United States
  • Company
  • RANA THERAPEUTICS ENTERS INTO LICENSING AGREEMENT WITH SANTARIS PHARMA TO DEVELOP RNA-TARGETED MEDICINES
  • JUN 27, 2017: RANA THERAPEUTICS RELAUNCHES AS TRANSLATE BIO TO ADVANCE RNA THERAPEUTICS

Summary Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression.The company provides platform oligonucleotides (oligos) are molecules designed to target specific areas...

  • Pharmaceutical
  • RNA
  • Therapy
  • United States
  • Company

It also provides sequencing services for miRNAs and other small RNAs from total RNA or from biofluid samples.

  • Pharmaceutical
  • RNA
  • United States
  • Company
  • Takara Bio Inc.
  • BIOSEARCH TECHNOLOGIES ENTERS INTO LICENSING AGREEMENT WITH RUTGERS UNIVERSITY FOR TURBOFISH TECHNOLOGY

Being able to perform a protocol in ## minutes (or sometimes as little as ## seconds) with virtually no loss in signal integrity marks a huge shift in our conception of what one can do with RNA FISH. "

  • Pharmaceutical
  • RNA
  • United States
  • M&A
  • Lucigen Corporation